Search results for "Epithelioma"

showing 10 items of 31 documents

Determination of oestrogen receptors with monoclonal antibodies in fine needle aspirates of breast carcinoma.

1989

Fifty patients with operable breast carcinoma underwent fine needle aspiration for cytological examination. The smears were prepared by means of the immunocytochemical method using monoclonal antibodies for the determination of the oestrogen receptors (ER). After surgery the contents of the ER were determined with the traditional biochemical technique. The results of the immunocytochemical method showed 31 positives, two of which disagreed with the biochemical results, 15 negatives and four cases which could not be assessed due to the absence of adequate numbers of cells. The ICA staining for ER was expressed on a semiquantitative basis; there was a significant correlation between this and …

AdultCancer ResearchPathologymedicine.medical_specialtymedicine.drug_classBreast NeoplasmsBiologyMonoclonal antibodyBiopsyCarcinomamedicineHumansAgedmedicine.diagnostic_testEpitheliomaBiopsy NeedleAntibodies MonoclonalMiddle Agedmedicine.diseaseStainingFine-needle aspirationOncologyReceptors EstrogenMonoclonalFemaleBreast carcinomaResearch ArticleBritish journal of cancer
researchProduct

CD10 and HHF35 actin in the differential diagnosis between Collagenous Spherulosis and Adenoid-Cystic Carcinoma of the breast

2012

Collagenous Spherulosis (CS) and Adenoid-Cystic Carcinoma (AdCC) of the breast consist of cribriform proliferations of epithelial and myoepithelial cells with an immunophenotypic overlap of some myoepithelial markers, such as p63 and smooth muscle actin (SMA). To our knowledge, CD10 and HHF35 actin have not been assessed in the differential diagnosis of these two breast lesions. We performed an immunohistochemical study on 6 cases of CS and 9 cases of AdCC. We found CD10, muscle-specific actin (HHF35), Estrogen and Progesterone receptors (ER and PR) to be strongly expressed in CS, but not in AdCC; C-kit was diffusely positive in AdCC and scanty in CS; SMA, p63 and Cytokeratine 5/6 (CK5/6) w…

AdultCell typePathologymedicine.medical_specialtyCollagenous SpherulosiAdenoid cystic carcinomaBreast NeoplasmsSettore MED/08 - Anatomia PatologicaHistogenesisBiologyMyoepitheliomaAdenoid-Cystic CarcinomaPathology and Forensic MedicineDiagnosis DifferentialImmunophenotypingimmune system diseasesBiomarkers TumormedicineCarcinomaHumansBreastAgedRetrospective StudiesMyoepithelial cellBreast; Collagenous Spherulosis; Adenoid-Cystic Carcinoma; CD10; HHF35Cell BiologyMiddle Agedmedicine.diseaseCarcinoma Adenoid CysticActinsCollagenous spherulosisCD10ImmunohistochemistryFemaleNeprilysinHHF35Breast Collagenous Spherulosis Adenoid-Cystic Carcinoma CD10 HHF35CollagenPathology - Research and Practice
researchProduct

O6-methylguanine-DNA methyltransferase activity in breast and brain tumors.

1995

The DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) is a main determinant of resistance of tumor cells to the cytostatic activity of chemotherapeutic alkylating agents (methylating and chloroethylating nitrosoureas) and is effective in protecting normal cells against genotoxic and carcinogenic effects resulting from DNA alkylation. Therefore, the level of expression of MGMT is significant for the response of both the tumor and the non-target tissue following application of nitrosoureas in tumor therapy. To determine the expression of MGMT in tumor tissue, we have assayed MGMT activity in 68 breast carcinomas and 38 brain tumors. There was a wide variation of MGMT expression…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyMethyltransferaseDNA RepairMammary glandBlotting WesternBreast NeoplasmsBiologyAstrocytomaO(6)-Methylguanine-DNA MethyltransferaseGliomaDNA Repair ProteinmedicineCarcinomaHumansneoplasmsCarcinogenAgedEpitheliomaL-Lactate DehydrogenaseBrain NeoplasmsAstrocytomaMethyltransferasesMiddle Agedmedicine.diseasedigestive system diseasesmedicine.anatomical_structureOncologyCancer researchFemaleGlioblastomaHeLa CellsInternational journal of cancer
researchProduct

Extra-tongue oral granular cell tumor : histological and immunohistochemical aspect

2017

Background Granular cell tumor (GCT) is an uncommon benign tumor founded in any part of the body but mainly in the tongue. Extra-tongue oral granular cell tumor (ETOGCT) is rare with few cases reported. Here we describe seven cases of oral GCT located in sites other then the tongue and discuss histopathological and immunohistochemical differences between differential diagnoses. Material and Methods We retrieved all cases diagnosed with oral granular cell tumor, from the Oral Pathology Service at the School of Dentistry/ University of São Paulo, and excluded the ones sited in the tongue. Immunohistochemical staining anti-S100 was also performed. Results The presented cases of Extra-tongue Or…

AdultMalePathologymedicine.medical_specialtyPseudoepitheliomatous HyperplasiaStainBenign tumor03 medical and health sciences0302 clinical medicineTongueOral and maxillofacial pathologyAtypiaMedicineHumansGeneral DentistryMouth neoplasmGranular cell tumorOral Medicine and Pathologybusiness.industryResearch030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Immunohistochemistrymedicine.anatomical_structureOtorhinolaryngologyGranular Cell Tumor030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgeryFemaleMouth Neoplasmsbusiness
researchProduct

Mucoepidermoid mammary carcinoma. Immunohistochemical and biochemical analyses of intermediate filaments.

1989

The histological features of mucoepidermoid mammary carcinomas (MMCs) are presented, and criteria for distinguishing these tumours from squamous epithelial metaplasia in other mammary carcinomas are considered. Immunohistochemical and gel-electrophoretic analyses of the intermediate-filament proteins in one MMC case revealed a complex pattern of cytokeratin polypeptide expression. The simple-epithelium-type cytokeratins 7, 8, 18, and 19 were detected mainly in nonsquamous (including mucinous) cells, while the stratified-epithelium-type cytokeratins 5, 6, 14, 16, and 17 were present in squamous cells. However, in both the nonsquamous and squamous regions of the tumour, cytokeratins of the "r…

AdultPathologymedicine.medical_specialtyIntermediate FilamentsBreast NeoplasmsHistogenesisBiologyMalignancyPathology and Forensic MedicineMetastasisCytokeratinGlial Fibrillary Acidic ProteinmedicineCarcinomaHumansVimentinMolecular BiologyAgedAged 80 and overEpitheliomaCarcinomaCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistrySquamous metaplasiaEpithelial MetaplasiaKeratinsFemaleVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Tumor Vascularity—A Novel Prognostic Factor in Advanced Cervical Carcinoma

1995

Objective: In the search for the optimal treatment of advanced cervical cancer, the identification of valid prognostic factors obtainable without histopathologic investigation of the entire tumor and the locoregional lymph nodes is of paramount interest. Tumor microvessel density has recently been demonstrated to correlate strongly with disease aggressiveness in breast cancer and other malignancies. Methods: We established a computerized image analysis system to quantify tumor microvascularity by using the closest-individual method, which determines the distribution of distances from random points within the tumor to the closest microvessel (DTCMV). Tumor microvascularity was assessed in pa…

Adultmedicine.medical_specialtyPathologyUterine Cervical NeoplasmsAdenocarcinomaDisease-Free SurvivalCarcinoma AdenosquamousBreast cancermedicineCarcinomaHumansProspective StudiesStage (cooking)Lymph nodeAgedNeoplasm StagingAged 80 and overCervical cancerEpitheliomabusiness.industryObstetrics and GynecologyMiddle AgedPrognosismedicine.diseasemedicine.anatomical_structureLymphatic systemOncologyCarcinoma Squamous CellRegression AnalysisFemaleHistopathologybusinessFollow-Up StudiesGynecologic Oncology
researchProduct

DNA image cytometry in stomach carcinoma. Its relation to histomorphologic parameters and its influence on prognosis

1992

BACKGROUND The influence of DNA content on the prognosis in stomach cancer is controversial. METHOD After curative resection of stomach carcinomas (adenocarcinomas [n = 58]; signet ring cell carcinomas [n = 24]; undifferentiated carcinomas [n = 21]), the influence of the DNA content and histomorphologic parameters on the prognosis was examined. RESULTS In the multivariate regression analysis, the prognosis depended on the lymph node status (P = 0.0009), pT stage (P = 0.02), tumor localization (P = 0.03), and histologic type (P = 0.05). The prognosis was independent of the DNA content. Furthermore, the degree of differentiation, operative procedure, safety distance, size of the tumor, and se…

Cancer ResearchPathologymedicine.medical_specialtyEpitheliomabusiness.industrySignet ring cellStomachmedicine.diseasemedicine.anatomical_structureOncologyCarcinomaMedicineAdenocarcinomabusinessStomach cancerLymph nodeDNA Image CytometryCancer
researchProduct

2021

Retinoblastoma and other eye tumors in childhood are rare diseases. Many eye tumors are the first signs of a genetic tumor predisposition syndrome and the affected children carry a higher risk of developing other cancers later in life. Clinical and genetic data of all children with eye tumors diagnosed between 2013–2018 in Germany and Austria were collected in a multicenter prospective observational study. In five years, 300 children were recruited into the study: 287 with retinoblastoma, 7 uveal melanoma, 3 ciliary body medulloepithelioma, 2 retinal astrocytoma, 1 meningioma of the optic nerve extending into the eye. Heritable retinoblastoma was diagnosed in 44% of children with retinoblas…

Cancer ResearchPediatricsmedicine.medical_specialtybusiness.industryRetinoblastomaGenetic counselingCancermedicine.diseaseeye diseasesMeningioma03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesis030221 ophthalmology & optometrymedicineGenetic predispositionNeurofibromatosisMedulloepitheliomabusinessDICER1 SyndromeCancers
researchProduct

Follow-up of patients with colonic polyps containing severe atypia and invasive carcinoma. Compliance, recurrence, and survival

1988

Between January 1975 and December 1984 1769 polyps were endoscopically removed from 1219 patients. Eight percent of these patients had polyps containing severe atypia and 5.0% had polyps containing invasive cancer. A close postoperative surveillance program was followed by only a few patients, but compliance improved with longer follow-up intervals. Metachronous polyps were observed with similar frequency in patients with benign polyps (34.8%) and those with polyps containing severe atypia (23.8%) or cancer (41.7%). Patients in whom malignant polyps were endoscopically removed had a 5-year survival rate of 84.3% that did not differ from that of patients' whose polyps contained severe atypia…

Cancer Researchmedicine.medical_specialtyColonic PolypsGastroenterologyActuarial AnalysisInternal medicineotorhinolaryngologic diseasesmedicineAtypiaCarcinomaHumansNeoplasm InvasivenessPatient complianceneoplasmsSurvival rateAgedRetrospective StudiesInvasive carcinomaEpitheliomabusiness.industryCarcinomaCancerEndoscopypathological conditions signs and symptomsMiddle Agedmedicine.diseasedigestive system diseasesBenign polypsSurgerysurgical procedures operativeOncologyPopulation SurveillancePatient ComplianceNeoplasm Recurrence LocalbusinessFollow-Up StudiesCancer
researchProduct

The effect of overall treatment time in radiotherapy for localized prostate carcinoma

1991

Cancer Researchmedicine.medical_specialtyRadiationEpitheliomabusiness.industryProstatic diseasemedicine.medical_treatmentTreatment outcomeProstate carcinomamedicine.diseaseSurgeryRadiation therapyOncologyCarcinomaMedicineRadiology Nuclear Medicine and imagingTreatment timeRadiologybusinessApplication methodsInternational Journal of Radiation Oncology*Biology*Physics
researchProduct